PL365040A1 - Zastosowanie fibratów do wytwarzania leku przydatnego do leczenia niewydolności zastoinowej serca - Google Patents

Zastosowanie fibratów do wytwarzania leku przydatnego do leczenia niewydolności zastoinowej serca

Info

Publication number
PL365040A1
PL365040A1 PL01365040A PL36504001A PL365040A1 PL 365040 A1 PL365040 A1 PL 365040A1 PL 01365040 A PL01365040 A PL 01365040A PL 36504001 A PL36504001 A PL 36504001A PL 365040 A1 PL365040 A1 PL 365040A1
Authority
PL
Poland
Prior art keywords
fibrates
preparation
treatment
heart failure
congestive heart
Prior art date
Application number
PL01365040A
Other languages
English (en)
Inventor
Arduino Arduini
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL365040A1 publication Critical patent/PL365040A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL01365040A 2000-08-01 2001-07-20 Zastosowanie fibratów do wytwarzania leku przydatnego do leczenia niewydolności zastoinowej serca PL365040A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000433A IT1317885B1 (it) 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.
PCT/IT2001/000390 WO2002009682A2 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure

Publications (1)

Publication Number Publication Date
PL365040A1 true PL365040A1 (pl) 2004-12-27

Family

ID=11454866

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365040A PL365040A1 (pl) 2000-08-01 2001-07-20 Zastosowanie fibratów do wytwarzania leku przydatnego do leczenia niewydolności zastoinowej serca

Country Status (18)

Country Link
US (2) US20030176499A1 (pl)
EP (1) EP1305020B1 (pl)
JP (1) JP2004505037A (pl)
KR (1) KR100844190B1 (pl)
CN (1) CN1798554A (pl)
AT (1) ATE330597T1 (pl)
AU (2) AU7768601A (pl)
BR (1) BR0112874A (pl)
CA (1) CA2415042C (pl)
CY (1) CY1106318T1 (pl)
DE (1) DE60120985T2 (pl)
ES (1) ES2267796T3 (pl)
IT (1) IT1317885B1 (pl)
MX (1) MXPA03000900A (pl)
PL (1) PL365040A1 (pl)
PT (1) PT1305020E (pl)
SK (1) SK287410B6 (pl)
WO (1) WO2002009682A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481371A1 (en) * 2002-03-11 2003-09-18 Peter Zahradka Use of ppar alpha agonists for the treatment of vascular and renal diseases
CN100347262C (zh) * 2003-11-13 2007-11-07 同济大学 一种水溶性建筑粘结剂及其制备方法
JP5317919B2 (ja) * 2009-10-05 2013-10-16 花王株式会社 Ｇｉｐ上昇抑制剤の評価又は選択方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208203A1 (es) * 1974-09-10 1976-12-09 Cortial Proceso para la preparacion de acido p-trialquilsilil benzoico y derivados del mismo
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4463013A (en) * 1982-04-09 1984-07-31 The Upjohn Company Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
AU4050797A (en) * 1996-08-02 1998-02-25 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
AU8182198A (en) * 1997-07-22 1999-02-16 Olin Corporation Copper alloy having magnesium addition
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0002667D0 (en) * 2000-02-04 2000-03-29 Glaxo Group Ltd medicamesnts
US7352911B2 (en) * 2003-07-31 2008-04-01 Hewlett-Packard Development Company, L.P. Method for bilateral filtering of digital images

Also Published As

Publication number Publication date
AU2001277686B2 (en) 2006-07-20
ES2267796T3 (es) 2007-03-16
EP1305020A2 (en) 2003-05-02
CA2415042A1 (en) 2002-02-07
ITRM20000433A0 (it) 2000-08-01
CY1106318T1 (el) 2011-10-12
SK1312003A3 (en) 2003-06-03
SK287410B6 (sk) 2010-09-07
WO2002009682A2 (en) 2002-02-07
WO2002009682A3 (en) 2002-04-18
PT1305020E (pt) 2006-10-31
CN1798554A (zh) 2006-07-05
ITRM20000433A1 (it) 2002-02-01
EP1305020B1 (en) 2006-06-21
DE60120985D1 (de) 2006-08-03
JP2004505037A (ja) 2004-02-19
ATE330597T1 (de) 2006-07-15
CA2415042C (en) 2009-06-23
US20030176499A1 (en) 2003-09-18
KR20030041953A (ko) 2003-05-27
IT1317885B1 (it) 2003-07-15
US20090221701A1 (en) 2009-09-03
BR0112874A (pt) 2003-07-01
AU7768601A (en) 2002-02-13
KR100844190B1 (ko) 2008-07-04
MXPA03000900A (es) 2003-10-06
DE60120985T2 (de) 2006-12-21

Similar Documents

Publication Publication Date Title
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
AP2003002755A0 (en) Guanidinobenzamides as mc4-r agonists
MY127290A (en) New use of flibanserin
GB0105772D0 (en) Use
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03007140A (es) Derivados de carbolina.
BG104329A (en) New method of treatment
AU2001266575A1 (en) Chemical compounds
MXPA02012076A (es) Compuestos quimicos.
AU3850600A (en) Dalda analogs and their use
AU2002221908A1 (en) Novel use of protein hydrolysates
TW200508199A (en) Novel compound
SG139747A1 (en) Inhibitors of the mutant form of kit
MXPA03001081A (es) Medicamento anti-inflamatorio.
AU4133400A (en) Cystic fibrosis medicaments
AU2001294673A1 (en) Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
MXPA02012472A (es) Compuestos quimicos.
AU7768601A (en) Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
WO2003024941A1 (en) Naphthalene compounds and use thereof as drugs
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
AU2002231288A1 (en) The use of a non-absorbable, non-digestible lipid for the treatment of hyperbilirubinemia
AU2003244636A1 (en) Hair care composition
WO2002017905A3 (en) Treatment of burns

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)